EUVIMEDEUVIMED entdecken
Crossref

Synergistic Combination of Oral Transcytotic Nanomedicine and Histone Demethylase Inhibitor for Enhanced Cancer Chemoimmunotherapy

Jing Zhang, Qiuyu Wei, Ying Piao, Shiqun Shao iD, Zhuxian Zhou iD, Jianbin Tang iD, Jiajia Xiang iD, Youqing Shen iD

ACS Nano · 2024

DOI: 10.1021/acsnano.4c14816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Jing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University,…. Hauptthemen laut MEDLINE: Nanomedicine, Doxorubicin, Immunotherapy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanomedicineDoxorubicinImmunotherapyAnimalsHumansMiceAdministration, OralHistone DemethylasesCell Line, TumorMice, Inbred BALB CMicellesDrug SynergismCell ProliferationFemale

Stichwörter der Autor:innen

PD-L1 downregulationchemoimmunotherapyimmunogenic cell deathoral nanomedicinesynergistic combinationtranscytosis

Substanzen

DoxorubicinHistone DemethylasesMicelles

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China.
  • Key Laboratory of Biomass Chemical Engineering of the Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China.

ORCID-Profile: Shiqun Shao, Zhuxian Zhou, Jianbin Tang, Jiajia Xiang, Youqing Shen

Förderung

  • National Key Research and Development Program of China
  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, J., Wei, Q., Piao, Y., Shao, S., Zhou, Z., Tang, J., Xiang, J., & Shen, Y. (2024). Synergistic Combination of Oral Transcytotic Nanomedicine and Histone Demethylase Inhibitor for Enhanced Cancer Chemoimmunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.4c14816

Vancouver

Zhang J, Wei Q, Piao Y, Shao S, Zhou Z, Tang J, et al. Synergistic Combination of Oral Transcytotic Nanomedicine and Histone Demethylase Inhibitor for Enhanced Cancer Chemoimmunotherapy. ACS Nano. 2024. doi:10.1021/acsnano.4c14816

BibTeX
@article{Zhang2024,
  author = {Zhang, Jing and Wei, Qiuyu and Piao, Ying and Shao, Shiqun and Zhou, Zhuxian and Tang, Jianbin and Xiang, Jiajia and Shen, Youqing},
  title = {Synergistic Combination of Oral Transcytotic Nanomedicine and Histone Demethylase Inhibitor for Enhanced Cancer Chemoimmunotherapy},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.4c14816}
}
Kostenlos starten →